SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-314859
Filing Date
2020-12-10
Accepted
2020-12-10 16:07:53
Documents
12
Period of Report
2020-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d13415d8k.htm   iXBRL 8-K 28068
  Complete submission text file 0001193125-20-314859.txt   152366

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20201204.xsd EX-101.SCH 3092
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20201204_lab.xml EX-101.LAB 18072
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20201204_pre.xml EX-101.PRE 11400
5 EXTRACTED XBRL INSTANCE DOCUMENT d13415d8k_htm.xml XML 3390
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 201380627
SIC: 2834 Pharmaceutical Preparations